Analyst Ratings for Madrigal Pharmaceuticals (MDGL)
MDGL Rating Summary
MDGL Price Target Summary
- Highest: $962.00 (Barclays)
- Lowest: $510.00 (Leerink)
- Average: $670.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$670.53 (+24.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$670.53 (+24.5%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/4/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
605.00 (N/A) |
482.00 (538.71) |
11.77% | Details |
| 7/27/2026 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
685.00 (N/A) |
544.51 (538.71) |
-1.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
